Core Points - Rosen Law Firm is reminding investors of CarMax, Inc. about the January 2, 2026 lead plaintiff deadline for a securities class action lawsuit [2][4] - Investors who purchased CarMax securities between June 20, 2025, and November 5, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3] Legal Action Details - The lawsuit alleges that CarMax's defendants made materially false and misleading statements regarding the company's growth prospects, which were overstated due to temporary market conditions [6] - The lawsuit claims that when the true details about CarMax's business operations were revealed, investors suffered damages [6] Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [5] - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [5]

Core Points - Rosen Law Firm is reminding investors of Avantor, Inc. (NYSE: AVTR) about the December 29, 2025 lead plaintiff deadline for a securities class action lawsuit [2][4] - Investors who purchased Avantor common stock between March 5, 2024, and October 28, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3][6] - The lawsuit alleges that Avantor misrepresented its competitive positioning and failed to disclose negative impacts from increased competition, leading to materially false and misleading statements about its business and prospects [6] Legal Action Details - Investors can join the class action by visiting the provided link or contacting the law firm directly [4][7] - The Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions [5] - No class has been certified yet, meaning investors are not represented unless they retain counsel [8]

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of investors in Telix Pharmaceuticals Ltd. for the period between February 21, 2025, and August 28, 2025, due to alleged misleading statements regarding the company's business and operations [1][5]. Group 1: Lawsuit Details - The class action lawsuit claims that Telix's defendants made materially false and misleading statements about the progress of prostate cancer therapeutic candidates and the quality of the company's supply chain and partners [5]. - Investors who purchased Telix securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Next Steps for Investors - Investors wishing to join the class action can do so by visiting the provided link or contacting the law firm directly [3][6]. - A lead plaintiff must move the Court by January 9, 2026, to represent other class members in the litigation [1][3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4].

Core Points - Rosen Law Firm has announced a class action lawsuit on behalf of investors who purchased securities of Stride, Inc. between October 22, 2024, and October 28, 2025, with a deadline for lead plaintiff applications set for January 12, 2026 [1][3] Group 1: Class Action Details - Investors who purchased Stride, Inc. securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6] - The lawsuit alleges that Stride made misleading statements regarding its products and services, inflating enrollment numbers and cutting staff costs beyond statutory limits, which led to investor damages when the truth was revealed [5] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company [4] - The firm has been ranked highly for its number of securities class action settlements and has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Core Viewpoint - Rosen Law Firm is encouraging investors of James Hardie Industries plc to secure legal counsel before the December 23, 2025 deadline for a securities class action lawsuit related to misleading statements about the company's performance during a specific period [2][4]. Group 1: Class Action Details - The class action pertains to investors who purchased James Hardie common stock between May 20, 2025, and August 18, 2025, and may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3][6]. - A lawsuit claims that James Hardie misled investors regarding the strength of its North America Fiber Cement segment, falsely asserting that demand was strong while distributors were actually destocking inventory [6]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [5]. - Rosen Law Firm has a history of significant settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions of dollars for investors [5].

Core Viewpoint - Rosen Law Firm is reminding investors of Inspire Medical Systems, Inc. to secure counsel before the January 5, 2026 deadline for a securities class action related to the company's stock performance during the specified class period [1][2]. Group 1: Class Action Details - Investors who purchased Inspire Medical common stock between August 6, 2024, and August 4, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by January 5, 2026 [3][5]. - The lawsuit alleges that Inspire Medical misrepresented key facts about its sleep apnea device, Inspire V, including market demand and necessary steps for its launch, leading to investor damages when the truth was revealed [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4].

Core Viewpoint - Rosen Law Firm is encouraging investors of CarMax, Inc. to secure legal counsel before the January 2, 2026 deadline for a securities class action lawsuit related to the company's misleading statements during the class period from June 20, 2025, to November 5, 2025 [1][5]. Group 1: Class Action Details - Investors who purchased CarMax securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by January 2, 2026 [3][6]. - The lawsuit alleges that CarMax's defendants made materially false statements regarding the company's growth prospects, which were overstated due to temporary market conditions [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been ranked highly for its number of securities class action settlements, recovering hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. - The founding partner of Rosen Law Firm was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, highlighting the firm's expertise and reputation in the field [4].

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of securities of Stride, Inc. for the period between October 22, 2024, and October 28, 2025, due to alleged misleading statements and omissions regarding the company's products and services [1][5]. Group 1: Lawsuit Details - The class action lawsuit claims that Stride, Inc. made misleading statements about its products and services aimed at public and private schools, which included inflated enrollment numbers and non-compliance with statutory requirements [5]. - Investors are entitled to compensation without any out-of-pocket fees through a contingency fee arrangement if they purchased Stride, Inc. securities during the Class Period [2]. Group 2: Next Steps for Investors - Investors wishing to join the class action can do so by visiting the provided link or contacting the law firm directly [3][6]. - A lead plaintiff must be appointed by January 12, 2026, to represent other class members in the litigation [1][3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has consistently ranked highly in securities class action settlements and has recovered hundreds of millions of dollars for investors [4].

Core Viewpoint - Rosen Law Firm is urging investors of Cytokinetics, Inc. to take action before the November 17, 2025 deadline related to a securities class action lawsuit concerning misleading statements about the company's New Drug Application for aficamten [2][6]. Group 1: Class Action Details - The class action pertains to investors who purchased Cytokinetics common stock between December 27, 2023, and May 6, 2025, and may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3][6]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by November 17, 2025 [4][6]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [5]. - Rosen Law Firm has a history of significant settlements, including over $438 million secured for investors in 2019, and has been recognized for its success in securities class action settlements [5]. Group 3: Case Allegations - The lawsuit alleges that Cytokinetics made false and misleading statements regarding the timeline for the NDA submission and approval process for aficamten, specifically regarding expected FDA approval in the second half of 2025 [6]. - The company failed to disclose material risks related to the submission of a Risk Evaluation and Mitigation Strategy, which could delay the regulatory process, leading to investor damages when the true information was revealed [6].